Neauvia

Created in 2012, Neauvia is distributed in more than 80 countries worldwide. Today, it stands as a high-growth multinational corporation with production sites and subsidiaries in Italy, Switzerland, France, Spain, Poland, Germany, the UK and the US. Neauvia offers clinically proven combined solutions for healthcare practitioners and patients.

Part of the MatexLab Group, which is backed by leading central European private equity firm Abris Capital, Neauvia is a pioneer in medical aesthetics and has developed ground-breaking synergistic smart combination therapies.